Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Total Liabilities: 2023-2024

Historic Total Liabilities for CG Oncology (CGON) over the last 2 years, with Dec 2024 value amounting to $21.4 million.

  • CG Oncology's Total Liabilities rose 169.22% to $42.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $42.3 million, marking a year-over-year increase of 169.22%. This contributed to the annual value of $21.4 million for FY2024, which is 47.61% up from last year.
  • CG Oncology's Total Liabilities amounted to $21.4 million in FY2024, which was up 47.61% from $14.5 million recorded in FY2023.
  • Over the past 5 years, CG Oncology's Total Liabilities peaked at $21.4 million during FY2024, and registered a low of $14.5 million during FY2023.
  • For the 2-year period, CG Oncology's Total Liabilities averaged around $18.0 million, with its median value being $18.0 million (2023).
  • Data for CG Oncology's Total Liabilities shows a peak YoY skyrocketed of 47.61% (in 2024) over the last 5 years.
  • Over the past 2 years, CG Oncology's Total Liabilities (Yearly) stood at $14.5 million in 2023, then surged by 47.61% to $21.4 million in 2024.